Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cumberland Pharmaceuticals Inc CPIX

Healthcare
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a... see more

Recent & Breaking News (NDAQ:CPIX)

Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2019 Financial Results

PR Newswire March 4, 2020

Cumberland Pharmaceuticals Announces The National Launch Of A New Caldolor Ready-To-Use Product

PR Newswire January 7, 2020

Cumberland Pharmaceuticals To Hold Update Call To Discuss Recent Major Developments

PR Newswire January 2, 2020

Cumberland Pharmaceuticals Receives FDA Approval for RediTrex(TM) Product Line

PR Newswire December 2, 2019

New Study Reveals Real-World Usage of Vibativ® In a Variety Of Infections

PR Newswire November 25, 2019

Cumberland Pharmaceuticals Reports 22% Revenue Growth In The Third Quarter

PR Newswire November 12, 2019

Cumberland Pharmaceuticals To Announce Third Quarter 2019 Financial Results

PR Newswire November 5, 2019

New Study Reveals Superiority Of Vibativ® Over Vancomycin In Select Patients With Bacterial Pneumonia

PR Newswire October 15, 2019

Cumberland Pharmaceuticals Announces FDA Orphan Drug Grant Award For New Phase II Clinical Program

PR Newswire September 24, 2019

Cumberland Pharmaceuticals Reports 14% Revenue Growth In The Second Quarter

PR Newswire August 14, 2019

Cumberland Pharmaceuticals To Announce Second Quarter 2019 Financial Results

PR Newswire August 7, 2019

Cumberland Pharmaceuticals Signs Exclusive Licensing Agreement For Distribution In China

PR Newswire May 15, 2019

Cumberland Pharmaceuticals Reports 38% Revenue Growth In The First Quarter

PR Newswire May 14, 2019

Cumberland Pharmaceuticals To Announce First Quarter 2019 Financial Results

PR Newswire May 7, 2019

Cumberland Pharmaceuticals Announces Strategic Review

PR Newswire March 29, 2019

Cumberland Pharmaceuticals Reports Fourth Quarter Revenue Growth Of 16%

PR Newswire February 26, 2019

Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2018 Financial Results

PR Newswire February 19, 2019

Cumberland Pharmaceuticals Reports Third Quarter 2018 Financial Results

PR Newswire November 13, 2018

Cumberland Pharmaceuticals To Announce Third Quarter 2018 Financial Results

PR Newswire November 7, 2018

Cumberland Pharmaceuticals To Acquire VIBATIV®

PR Newswire November 6, 2018